Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.62 -2.21 (-2.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Common Equity (2010 - 2026)

Updated

Ani Pharmaceuticals' Common Equity was $597.21 million in Q2 2026, up 36.7% from $436.76 million a year earlier and up 6.2% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Common Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at Ani Pharmaceuticals came in at $540.72 million, up 33.9% from FY2024.

  • Common Equity shows a five-year compound annual growth rate of 22.5% (FY2020 to FY2025).
  • In earlier years, Common Equity was $403.68 million in FY2024 (-6.7%), $432.75 million in FY2023 (+38.0%), $313.69 million in FY2022 (-6.0%) and $333.89 million in FY2021 (+70.6%).
  • The Q2 2026 figure marks the highest quarterly Common Equity in data going back to Q4 2010.
  • Compared with a year earlier, Common Equity has increased for four straight quarters, with growth averaging 13.2% over the last eight quarters.
  • The best year-over-year quarter for Common Equity over five years was Q4 2021 (growth of 70.6%); the worst was Q1 2025 (a decline of 7.4%).
  • Per Business Quant data, ANIP's Common Equity in the three quarters before Q2 2026 was $562.3 million (Q1 2026), $540.72 million (Q4 2025) and $505.82 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Ani Pharmaceuticals 1.78 Bn 565.34 Mn 165.89 Mn 597.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 597.21 Mn
Mar 31, 2026 562.30 Mn
Dec 31, 2025 540.72 Mn
Sep 30, 2025 505.82 Mn
Jun 30, 2025 436.76 Mn
Mar 31, 2025 418.62 Mn
Dec 31, 2024 403.68 Mn
Sep 30, 2024 405.95 Mn
Jun 30, 2024 455.76 Mn
Mar 31, 2024 451.96 Mn
Dec 31, 2023 432.75 Mn
Sep 30, 2023 429.86 Mn
Jun 30, 2023 409.62 Mn
Mar 31, 2023 314.63 Mn
Dec 31, 2022 313.69 Mn
Sep 30, 2022 311.83 Mn
Jun 30, 2022 312.11 Mn
Mar 31, 2022 321.24 Mn
Dec 31, 2021 333.89 Mn
Sep 30, 2021 191.40 Mn
API Access

Ani Pharmaceuticals Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=ANIP&period=max&api_key=YOUR_API_KEY